A meta-analysis of the dose-response relationship of inhaled corticosteroids in adolescents and adults with mild to moderate persistent asthma

Clinical Therapeutics

Volumn 24, Issue 1, 2002, Pages 1-20

  Bousquet, Jean ^a   Ben Joseph, Rami ^b   Messonnier, Mark ^b   Alemao, Evo ^c   Lawrence Gould, A ^b  

^a HÔPITAL ARNAUD DE VILLENEUVE   (France)

^b MERCK RESEARCH LABORATORIES   (United States)

^c RUTGERS UNIVERSITY   (United States)

Author keywords

Asthma; Corticosteroids; Dose response; Meta analysis

Indexed keywords

BECLOMETASONE; BUDESONIDE; CORTICOSTEROID; FLUNISOLIDE; FLUTICASONE; FLUTICASONE PROPIONATE; GLUCOCORTICOID; MOMETASONE FUROATE; TRIAMCINOLONE ACETONIDE;

ASTHMA; CLINICAL TRIAL; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFICACY; DRUG UTILIZATION; FORCED EXPIRATORY VOLUME; HUMAN; META ANALYSIS; OUTCOMES RESEARCH; PEAK EXPIRATORY FLOW; REVIEW; SCORING SYSTEM; SYMPTOM;

EID: 0036165978     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/S0149-2918(02)85002-0     Document Type: Article

References (57)

1. Inhaled corticosteroids: Benefits and risks
2. Issues in the use of inhaled glucocorticoids
3. Mometasone furoate antagonizes AMP-induced bronchoconstriction in patients with mild asthma
4. A double-blind dose-response study of budesonide by inhalation in patients with bronchial asthma
5. Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to longterm treatment
6. Systemic effects of inhaled fluticasone propionate and budesonide in adult patients with asthma
7. Substitution of beclomethasone aerosol for oral prednisolone in the treatment of chronic asthma
8. Beclomethasone dipropionate aerosol in asthma. Transfer of steroid-dependent asthmatic patients from oral prednisone to beclomethasone dipropionate aerosol
9. Double-blind trial comparing two dosage schedules of beclomethasone dipropionate aerosol in the treatment of chronic bronchial asthma. Preliminary report of the Brompton Hospital-Medical Research Council collaborative trial
10. Beclomethasone dipropionate aerosol in the treatment of steroid-dependent asthma. A 12-week double-blind study comparing beclomethasone dipropionate and a vehicle aerosol
11. High-dose beclomethasone: Oral steroid-sparing effect in severe asthmatic patients
12. Oral glucocorticosteroid-sparing effect of budesonide administered by Turbuhaler: A double-blind, placebo-controlled study in adults with moderate-to-severe chronic asthma
13. Budesonide delivered by Turbuhaler is effective in a dose-dependent fashion when used in the treatment of adult patients with chronic asthma
14. Fluticasone propionate results in improved glucocorticoid receptor binding affinity and reduced oral glucocorticoid requirements in severe asthma
15. Oral steroid-sparing effect of two doses of nebulized fluticasone propionate and placebo in patients with severe chronic asthma
16. Fluticasone propionate powder: Oral corticosteroid-sparing effect and improved lung function and quality of life in patients with severe chronic asthma
17. Dose-related efficacy of budesonide administered via a dry powder inhaler in the treatment of children with moderate to severe persistent asthma
18. Addition of salmeterol versus doubling the dose of beclomethasone in children with asthma
19. A multiple-dosing, placebo-controlled study of budesonide inhalation suspension given once or twice daily for treatment of persistent asthma in young children and infants
20. The effect of inhaled fluticasone propionate in the treatment of young asthmatic children
21. Clinical efficacy of low-dose inhaled budesonide once or twice daily in children with mild asthma not previously treated with steroids
22. Inhaled fluticasone propionate delivered by means of two different multidose powder inhalers is effective and safe in a large pediatric population with persistent asthma
23. Low-dose inhaled budesonide once or twice daily for 27 months in children with mild asthma
24. Low-dose budesonide improves exercise-induced bronchospasm in schoolchildren
25. Efficacy and safety of budesonide inhalation suspension (Pulmicort Respules) in young children with inhaled steroid-dependent, persistent asthma
26. The efficacy and safety of budesonide inhalation suspension: A nebulizable corticosteroid for persistent asthma in infants and young children
27. Once-daily budesonide inhalation suspension for the treatment of persistent asthma in infants and young children
28. Bayesian approaches to random-effects meta-analysis: A comparative study
29. Comparative efficacy and safety of twice daily fluticasone propionate powder versus placebo in the treatment of moderate asthma
30. Fluticasone propionate aerosol for the treatment of adults with mild-to-moderate asthma
31. Effectiveness of fluticasone propionate in patients with moderate asthma: A dose-ranging study
32. Fluticasone propionate compared with theophylline for mild-to-moderate asthma
33. Fluticasone propionate aerosol: Efficacy in patients with mild-to-moderate asthma
34. Dose-related response to inhaled fluficasone propionate in patients with methacholine-induced bronchial hyperresponsiveness: A double-blind, placebo-controlled study
35. A dose-ranging study of fluticasone propionate administered once daily via multidose powder inhaler to patients with moderate asthma
36. Inhaled salmeterol and fluticasone: A study comparing monotherapy and combination therapy in asthma
37. A controlled trial of chlorofluorocarbon-free triamcinolone acetonide inhalation aerosol in the treatment of adult patients with persistent asthma
38. Placebo-controlled, comparative study of the efficacy and safety of triamcinolone acetonide inhalation aerosol with the non-CFC propellant HFA-134a in patients with asthma
39. Dose-ranging study of the clinical efficacy of twice-daily triamcinolone acetonide inhalation aerosol in moderately severe asthma
40. Administration of budesonide once daily by means of Turbuhaler to subjects with stable asthma
41. A double-blind, placebo-controlled dose-response study with budesonide Turbuhaler in Japanese asthma patients
42. Effect of differing doses of inhaled budesonide on markers of airway inflammation in patients with mild asthma
43. Mometasone furoate administered once daily is as effective as twice-daily administration for treatment of mild-to-moderate persistent asthma
44. Once-daily mometasone furoate dry powder inhaler in the treatment of patients with persistent asthma
45. Rapid onset of control with budesonide Turbuhaler in patients with mild-to-moderate asthma
46. Dose-ranging study of a new steroid for asthma: Mometasone furoate dry powder inhaler
47. A 12-week dose-ranging study of fluticasone propionate powder in the treatment of asthma
48. Efficacy response of inhaled beclomethasone dipropionate in asthma is proportional to dose and is improved by formulation with a new propellant
49. Inhaled beclomethasone at different doses for long term asthma
50. Minimum dose requirements of steroid-dependent asthmatic patients for aerosol beclomethasone and oral prednisone
51. An economic evaluation of asthma in the United States
52. A comparison of fluticasone propionate, 1 mg daily, with beclomethasone dipropionate, 2 mg daily, in the treatment of severe asthma
53. Fluticasone propionate reduces oral prednisone use while it improves asthma control and quality of life